Investors/Media

News Release

Printer Friendly Version View printer-friendly version
<< Back
Infinity Pharmaceuticals to Present at Two Upcoming Conferences

CAMBRIDGE, Mass., Apr 13, 2012 (BUSINESS WIRE) --Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 20, 2012, at 11:00 a.m. ET in New York City.

In addition, Infinity will also be presenting at the Deutsche Bank 37th Annual Healthcare Conference on Monday, May 7, 2012, at 10:40 a.m. ET in Boston.

A live webcast of both Infinity presentations will be accessible on the "investors/media" section of the company's website, www.infi.com, and will be available for 30 days following the applicable event.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs focused on the inhibition of the Hedgehog pathway, heat shock protein 90 and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at www.infi.com.

SOURCE: Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.
Jaren Irene Madden, 617-453-1336
Jaren.Madden@infi.com
http://www.infi.com